PEGylation renders carnosine resistant to hydrolysis by serum carnosinase and increases renal carnosine levels
Amino Acids · 2024
DOI: 10.1007/s00726-024-03405-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Amino Acids, 2024. Verfasst von Shiqi Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The first affiliated hospital of Anhui Medical University, Hefei, 230022, China. zhangshiqi@ahmu.edu.cn. Hauptthemen laut MEDLINE: Carnosine, Polyethylene Glycols, Dipeptidases, Kidney. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Carnosine’s protective effect in rodent models of glycoxidative stress have provided a rational for translation of these findings in therapeutic concepts in patient with diabetic kidney disease. In contrast to rodents however, carnosine is rapidly degraded by the carnosinase-1 enzyme. To overcome this hurdle, we sought to protect hydrolysis of carnosine by conjugation to Methoxypolyethylene glycol amine (mPEG-NH 2 ). PEGylated carnosine (PEG-car) was used to study the hydrolysis of carnosine by human serum as well as to compare the pharmacokinetics of PEG-car and L-carnosine in mice after intravenous (IV) injection. While L-carnosine was rapidly hydrolyzed in human serum, PEG-car was highly resistant to hydrolysis. Addition of unconjugated PEG to carnosine or PEG-car did not influence hydrolysis of carnosine in serum. In mice PEG-car and L-carnosine exhibited similar pharmacokinetics in serum but differed in half-life time (t 1/2 ) in kidney, with PEG-car showing a significantly higher t 1/2 compared to L-carnosine. Hence, PEGylation of carnosine is an effective approach to prevent carnosine degradations and to achieve higher renal carnosine levels. However, further studies are warranted to test if the protective properties of carnosine are preserved after PEGylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, The first affiliated hospital of Anhui Medical University, Hefei, 230022, China. zhangshiqi@ahmu.edu.cn.
- Department of Endocrinology, The first affiliated hospital of Anhui Medical University, Hefei, 230022, China.
- Department of Nuclear Medicine, Provincial Peoplès Hospital, Anhui No. 2, Hefei, 230041, China.
- Department of Pharmacy, The first affiliated hospital of Anhui Medical University, Hefei, 230022, China.
- Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
- Vth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Center Mannheim, University of Heidelberg, 68167, Mannheim, Germany.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, S., Yang, G., Zhang, Q., Fan, Y., Tang, M., Shen, L., Zhu, D., Zhang, G., & Yard, B. (2024). PEGylation renders carnosine resistant to hydrolysis by serum carnosinase and increases renal carnosine levels. Amino Acids. https://doi.org/10.1007/s00726-024-03405-6
Vancouver
Zhang S, Yang G, Zhang Q, Fan Y, Tang M, Shen L, et al. PEGylation renders carnosine resistant to hydrolysis by serum carnosinase and increases renal carnosine levels. Amino Acids. 2024. doi:10.1007/s00726-024-03405-6
BibTeX
@article{Zhang2024,
author = {Zhang, Shiqi and Yang, Guang and Zhang, Qinqin and Fan, Yuying and Tang, Mingna and Shen, Liuhai and Zhu, Dongchun and Zhang, Guiyang and Yard, Benito},
title = {PEGylation renders carnosine resistant to hydrolysis by serum carnosinase and increases renal carnosine levels},
journal = {Amino Acids},
year = {2024},
doi = {10.1007/s00726-024-03405-6}
}
EUVIMED